Pathstone Holdings
IMGN

Pathstone Holdings’s Immunogen Inc IMGN Stock Holding History

Pathstone Holdings’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,428
Closed -$635K – 2369
2023
Q4 		$635K Buy
+21,428
New +$427K ﹤0.01% 1363

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pathstone Holdings's IMGN Position: Q1 2024 in Review

Pathstone Holdings sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 21,428 shares — an estimated $635K sold.

Pathstone Holdings first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $635K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Pathstone Holdings reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Pathstone Holdings sold 21,428 Immunogen Inc shares in Q1 2024, an estimated $635K.
  • Pathstone Holdings first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Pathstone Holdings's Immunogen Inc position peaked at $635K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Pathstone Holdings's 13F filing for Q1 2024, filed 13 May 2024.